Business Context and Reporting Period
Company: ProCap Acquisition Corp (PCAP)
Reporting Period: Quarter ended March 31, 2025 (Inception: January 2, 2025)
Business Type: Cayman Islands exempted corporation formed as a "blank check" company (SPAC) to effect a business combination.
Status: As of March 31, 2025, the Company had not commenced operations. The Initial Public Offering (IPO) was consummated subsequently on May 22, 2025.
Key Financial Metrics (As of March 31, 2025)
| Metric | Value |
|---|---|
| Revenue | $0 (No operations) |
| Net Loss | $(70,019) |
| Cash and Cash Equivalents | $0 |
| Total Assets | $244,209 |
| Total Liabilities | $289,228 |
| Shareholder's Deficit | $(45,019) |
| Working Capital Deficit | $(264,228) |
| Promissory Note (Related Party) | $100,895 |
| Deferred Offering Costs | $219,209 |
Material Changes and Subsequent Events
The financial statements reflect the pre-IPO period. Significant capital events occurred subsequent to the reporting period:
- IPO Completion: On May 22, 2025, the Company consummated an IPO of 25,000,000 Units at $10.00 per unit, generating gross proceeds of $250,000,000.
- Private Placement: Simultaneously, the Sponsor purchased 430,000 Private Placement Units for $4,300,000.
- Trust Account: $250,000,000 was deposited into a Trust Account.
- Transaction Costs: Total transaction costs were $14,026,609, including a $2,200,000 cash underwriting fee and $11,250,000 deferred underwriting fee.
- Share Recapitalization: On May 20, 2025, the Sponsor received an additional 575,000 founder shares, bringing the total to 6,325,000 Class B shares.
Outlook, Risks, and Management Commentary
- Going Concern: Prior to the IPO, the Company had a working capital deficit and relied on a related-party promissory note. Management determined that post-IPO proceeds provide sufficient funds to finance working capital needs for at least one year.
- Business Combination Timeline: The Company has 24 months from the IPO closing (May 22, 2025) to complete a business combination. If unsuccessful, the Company will liquidate and redeem public shares.
- Internal Controls: Management identified a material weakness in internal controls over financial reporting as of December 31, 2024, citing inadequate segregation of duties and insufficient written policies due to limited personnel.
- Risk Factors: Risks include geopolitical instability (Russia-Ukraine, Israel-Hamas conflicts), potential trade policy changes/tariffs, and the inability to identify a suitable target business.
- Related Party Obligations: The Sponsor has agreed to loan up to $300,000 for IPO expenses (currently $100,895 outstanding) and may provide working capital loans up to $1,500,000 convertible into units.
Investor Verification Checklist
- Verify the final amount of funds remaining in the Trust Account after the deduction of the $2,200,000 cash underwriting fee and any taxes payable.
- Confirm the status of the $11,250,000 deferred underwriting fee and the conditions for its payment upon business combination.
- Review the specific terms of the Sponsor's indemnity obligation regarding third-party claims that could reduce Trust Account funds below $10.00 per share.
- Monitor the Company's progress in addressing the material weakness in internal controls over financial reporting.
- Track the exercise of the remaining 300,000 units under the underwriters' over-allotment option (45-day window from IPO).